3 New Strong Buy Ratings from Top-Rated Analysts: 12/26/2025

Here’s the good stuff from our most popular screener, curated and delivered: 

• Discover why Orla Mining (ORLA) is our Stock of the Week 
• Viatris (VTRS) is a low-priced stock with excellent potential 
• Why Ross Stores (ROST) could benefit from the busy shopping season

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

1. Orla Mining Ltd (NYSEMKT: ORLA)

Orla Mining is on a tear—trading near 52-week highs with explosive momentum, a stunning 203% return since 2020, and a top-tier #2 ranking in the gold industry.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $14.75 — get current quote

Max 1-year forecast: $27.00

Why we're watching:

• Only one analyst we track currently issues a rating on ORLA, but CiBC researcher Cosmos Chiu (a top 17% rated analyst) maintains a Buy rating with a $27.00 price target, representing +90.41% upside potential.  
• The analyst remains bullish on the company's strategic initiatives to enhance operational efficiencies, with recent improvements and cost controls expected to significantly boost margins.
• ORLA was also a recent Stock of the Week pick — see why our Editor-in-Chief calls it “the best gold stock of 2026”
• Industry ranking context: ORLA is currently the 2nd highest-rated stock in the Gold industry, which has an Industry Rating of A.
• Zen Rating highlights: With its A (Strong Buy) rating, ORLA is in the top tier of the 4600+ stocks we track.
• Component Grades: Growth rated B (95th percentile) reflects forecasted EPS growth of 382.88% in the first year and 770.38% over two years, while Momentum rated A (85th percentile) captures the stock's 166.04% climb from its 52-week low. See all 7 Zen Component Grades here

2. Viatris Inc (NASDAQ: VTRS)

Viatris just unlocked fresh upside with FDA approval of generic Sandostatin and a strategic monetization of its Biocon Biologics stake, sharpening its capital allocation story.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $11.96 — get current quote

Max 1-year forecast: $15.00

Why we're watching:

• Analyst support: Both of the analysts we track covering VTRS rate it Strong Buy, reflecting strong conviction in the company's turnaround potential. See the ratings
• For example, Truist Securities researcher Srikripa Devarakonda (a top 13% rated analyst) initiated coverage on the stock with a Strong Buy rating and $15.00 price target, representing nearly 25% upside potential. 
• The company's strategic decision to monetize its Biocon Biologics equity stake demonstrates management's focus on optimizing the capital structure and returning value to shareholders.
• Industry ranking context: VTRS is currently the 12th highest-rated stock out of 58 (See the rest of the stocks here)  in the Pharmaceutical industry, which has an Industry Rating of B.
• Zen Rating highlights: VTRS is an A, or Strong Buy, rated stock. It ranks among the top-rated pharmaceutical companies with consensus analyst upside of nearly 25%.
• Component Grades: The stock earns solid B grades in both Value and Growth, indicating attractive valuation alongside expansion potential, complemented by a B rating in Safety. See all 7 Zen Component Grades here

3. Ross Stores (NASDAQ: ROST)

Ross Stores is a retail powerhouse—trading near 52-week highs with a $59B market cap and an eye-popping 7,900%+ return since 1997, ranking among the very best in apparel.

Zen Rating: B (Buy) — see full analysis

Recent Price: $182.41 — get current quote

Max 1-year forecast: $200.00

Why we're watching:

• Analyst support: The retail giant has strong Wall Street backing, with 8 Strong Buy and 2 Buy ratings RN, reflecting confidence in the discount retail model. See the ratings
• Wells Fargo's Ike Boruchow (a top 5% rated analyst) maintains a Strong Buy with a $200.00 price target (+9.64% upside), suggesting potential growth and solid market positioning with optimism around strategic initiatives led by management.
• Recent analyst commentary emphasizes market resilience, growth in same-store sales, and effective inventory management as key drivers, with expected new store openings and holiday sales providing catalysts.
• Industry ranking context: ROST is currently the 4th highest-rated stock in the Apparel industry, which has an Industry Rating of B.
• Zen Rating highlights: As a B (Buy) rated stock, ROST is in a class of stocks that have historically averaged 19.88% returns annually — better than the S&P.
• Component Grades: ROST has above-average Bs for Financials, Sentiment, and from our all-seeing AI Factor.  See all 7 Zen Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.